Mayo Clinic study: Antibody-rich plasma treatment reduced deaths for COVID-19 patients


Photo credits: nypost.com


Blood plasma transfusions with high concentrations of COVID-19 antibodies reduced deaths among some virus patients, according to a new study conducted by Mayo Clinic researchers, lending credibility to one of the few known treatments for the illness.


“Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of Covid-19,” the researchers concluded.


For the full story click here.

0 comments